T2D |
Type 2 diabetes |
eGFR |
Estimated glomerular filtration rate |
DKD |
Diabetic kidney disease |
BMI |
Body mass index |
SBP |
Systolic blood pressure |
HbA1c |
Glycated hemoglobin concentration |
LDL |
Low-density lipoprotein |
HDL |
High-density lipoprotein |
ACR |
Albumin-to-creatinine ratio |
NAPCR |
Nonalbumin protein-to-creatinine ratio |
PCR |
Urine protein-to-creatinine ratio |
GPG |
Good-prognostic group |
PPG |
Poor-prognostic group |
LC-MS |
Liquid chromatography–mass spectrometry |
DAP |
Differential abundant protein |
GO |
Gene ontology |
FDR |
False discovery rate |
ROC |
Receiver operating characteristic |
AUC |
Area under the receiver operating characteristic curve |
RF |
Random forest |
SVM |
Support vector machine |
ELISA |
Enzyme-linked immunosorbent assay |
CKD |
Chronic kidney disease |
MS/MS |
Tandem mass spectrometry |
LFQ |
Label-free quantitation |
NSF |
Normalization scaling factor |
DN |
Diabetic nephropathy |
FSGS |
Focal and segmental glomerulosclerosis |
FSGS&MCD |
Focal and segmental glomerulosclerosis and minimal change disease |
HT |
Hypertensive nephropathy |
MCD |
Minimal change disease |
MGN |
Membranous glomerulonephritis |
RPGN |
Rapidly progressive glomerulonephritis |
SLE |
Systemic lupus erythematosus |
TMD |
Thin membrane disease |
TN |
Tumor nephrectomies |